Boston University

Boston University is an international, comprehensive, private research university, committed to educating students to be reflective, resourceful individuals ready to live, adapt, and lead in an interconnected world. Boston University is committed to generating new knowledge to benefit society. We remain dedicated to our founding principles: that higher education should be accessible to all and that research, scholarship, artistic creation, and professional practice should be conducted in the service of the wider community—local and international. These principles endure in the University’s insistence on the value of diversity, in its tradition and standards of excellence, and in its dynamic engagement with the City of Boston and the world. Boston University comprises a remarkable range of undergraduate, graduate, and professional programs built on a strong foundation of the liberal arts and sciences. With the support and oversight of the Board of Trustees, the University, through our faculty, continually innovates in education and research to ensure that we meet the needs of students and an ever-changing world.

Robert Brown

President

GE

Gillian Emmons

Associate VP and University Comptroller

MH

Martin Howard

SVP, CFO and Treasurer

CH

Clarissa Hunnewell

CIO

LH

Lila Hunnewell

CIO

25 past transactions

CardioFocus

Series B in 2000
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders. The company specializes in providing electrophysiologists with innovative and effective tools that bring new levels of precision and control to the treatment of atrial fibrillation that focuses on developing, manufacturing, and investigating disposable fiber optic catheters for the visualization of the cardiac anatomy and the treatment of cardiac arrhythmias. CardioFocus was founded in 1990 and is headquartered in Marlborough, Massachusetts.

Sandburst Corporation

Series C in 2004
Sandburst Corporation is a fabless semiconductor company, is pioneering a revolutionary new technology for the design of highly complex integrated circuits. For both Sandburst and its customers, this technology substantially reduces development costs and enables a shorter time-to-market. Sandburst is currently developing VLSI solutions specifically targeted at data communications and IP networking. These wire-speed IP packet processing components provide a solid foundation for high-performance systems without requiring the major software development effort needed for general-purpose programmable devices.

CardioFocus

Series A in 1998
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders. The company specializes in providing electrophysiologists with innovative and effective tools that bring new levels of precision and control to the treatment of atrial fibrillation that focuses on developing, manufacturing, and investigating disposable fiber optic catheters for the visualization of the cardiac anatomy and the treatment of cardiac arrhythmias. CardioFocus was founded in 1990 and is headquartered in Marlborough, Massachusetts.

CytoLogix

Series B in 2001
CytoLogix is a private company that focuses on developing laboratory instrumentation for non-routine complex stains. The company develops the Artisan, a tissue staining instrument used primarily for cancer diagnosis. It claims that the instrument was the first instrument to provide true walk-away automation for both immunohistochemical and complex special stains.

OutStart

Venture Round in 2002
OutStart provides social business software and learning systems that act like a lifeline: connecting people to the know-how, creativity, and learning they require to be efficient, effective, and agile.

Reef Point Systems

Venture Round in 2000
As of December 2007, Reef Point Systems, Inc. was acquired by NextPoint Networks, Inc. Reef Point Systems, Inc. provides security solutions for converged wireless and wireline networks in the United States. Its iQ product portfolio enables fixed/mobile convergence security, secure mobile access, network infrastructure protection, and managed security services. It enables operators to secure voice over the Internet protocol, Internet protocol television, and voice, video, and data services from a converged Internet protocol infrastructure. The company’s iQ family lets wireless service providers protect the wireless network infrastructure and deliver multimedia services for mobile users over unlicensed mobile access and Internet protocol multimedia subsystem infrastructure. Its products also enable service providers to offer various security services, including virtual private networks, firewalls, denial of service attack prevention, content filtering, and remote access. The company, formerly known as Quarry Technologies, Inc., was founded in 1998 and is headquartered in Burlington, Massachusetts.

Ensemble Discovery

Series B in 2007
Ensemble Discovery is developing a new class of therapeutics - the Ensemblinsâ„¢, orally bioavailable small molecule macrocyclic compounds that have the potential to behave like biologics and can disrupt protein-protein interactions. They have two complementary platforms that provide access to these molecules. Firstly, they use their proprietary DNA-Programmed Chemistryâ„¢ (DPCâ„¢) platform to generate hundreds of thousands of these molecules for rapid screening. Secondly, they have highly developed methods for the synthesis of Ensemblins as discrete molecules using conventional chemistry.

Constant Therapy, Inc.

Seed Round in 2014
Constant Therapy, Inc. provides a science-based mobile solution for personalized and continuous therapy tools to patients with traumatic brain injury, stroke, aphasia, and learning disabilities. It offers NeuroPerformance Engine, an analytics engine that creates personalized exercises for patients improving their cognitive, language, and learning skills continuously and transforming the delivery of brain rehabilitation. The company’s application also provides tasks, such as auditory, naming, phonological, reading, writing, production, attention, visual, memory, problem solving, and everyday skills. It serves clinicians, special educators, and patients. The company was founded in 2012 and is based in Newton, Massachusetts. As of May 31, 2017, Constant Therapy, Inc. operates as a subsidiary of Digital Health Corp.

SilverBack Technologies

Series B in 2000
As of November 29, 2007, SilverBack Technologies, Inc. was acquired by Dell Inc. SilverBack Technologies, Inc. provides products and services to manage applications, systems, and networks. The company's DataCenter enterprise product is a distributed and multi-tenant platform for providing remote management across the networks. It is a service delivery platform provider for remote monitoring and management of information technology infrastructure, such as servers, storage, networks, desktops, and notebooks. The company offers patch management and deployment, remote access, remote scripting, software distribution, file transfer, and desktop management solutions; and monitoring solutions, such as proactive monitoring, event management, security monitoring, knowledge base, dashboard, and alert management solutions. It also offers reporting solutions that include executive reports, performance scorecards, security scorecards, monthly service reports, technical reports, and long-term trending reports; and hosted packages, including monitoring licenses, patch scanning and deployment, vulnerability scanning, reporting, remediation, product training, sales and marketing assistance, and maintenance and support. It serves banking, education, legal, and medical sectors, as well as managed service providers, application developers, independent software vendors, hardware vendors, value-added resellers, system integrators, and end customers. The company was founded in 1999 and is based in Billerica, Massachusetts.

Emperative

Series B in 2000
Emperative® delivers provisioning software products and solutions that enable optical, cable, Digital Subscriber Line (DSL), and wireless providers to parlay isolated network and service components into integrated, money-making products and services. Founded in 1998, Emperative set out to create a product that would enable a true service provisioning environment, where providers could create lucrative services based on the needs of people rather than networks, and where users could subscribe to services on demand, in real-time without the need for a customer service representative.

CauseEDU

Grant in 2018
CauseEDU is a financial planning platform that helps students and their families select the best colleges and graduate schools and develop sound strategies to pay for them.

Downtyme

Seed Round in 2014
Downtyme is a computer software company working to develop an Android and iOS application, which allows a user to schedule free time with other users who have mutual free time. The company's vision is to change the way technology brings friends together face-to-face by reducing that lack of human connection we all experience far too often, mostly due to noticeable “distances” the Internet and mobile devices have created. This intelligent app uses sophisticated algorithms that instantly tell you which of your best friends are available (and close-by), and then lets you send them an invite for Downtyme. The user logs into the application, which imports his or her current phone's schedule (or it can be input manually) to determine windows of free time. Users can send out requests to other available friends for lunch, study time, or any other activity. The app also allows you to coordinate get-togethers ahead of time through its separate "later" view displaying the current week. Privacy is maintained because a user cannot view other people's schedules, but only see whether or not they are free. Users can choose to hide themselves from public view during free time blocks with one simple click.

Artel Video Systems

Series B in 2000
At Artel, they recognize the changes and leveraged their 30 years of video transport experience to develop DigiLink, a reliable and simple-to-deploy media transport platform designed to take advantage of newer networks. The result is a space efficient, low power, easy-to-deploy and manage platform with thousands of successful deployments worldwide and an unparalleled reputation for reliability. DigiLink is also the most flexible platform on the market integrating video and Ethernet routing with fiber, IP, and optical network transport capabilities. DigiLink combined with their long history of exceptional customer service, and free lifetime technical support and training make Artel the ideal partner for your media transport needs.

Wheelock College

Acquisition in 2017
As of June 29, 2018, Wheelock College was acquired by Boston University.

Beansprout.net

Series C in 2000
Beansprout offers customizable websites to pediatricians, licensed childcare distributors, and childcare resources. It builds an online hub to connect parents with their pediatricians as well as provides a forum for distributors of goods and services to the audiences. The company’s product, the Good Health Program, provides doctors with patient education tools that are placed in the examination rooms of select practices in the network. Beansprout is a U.S.-based company that was founded in 1998 and the company was acquired by Innovex on November 5, 2002.

Parkaze, Inc.

Grant in 2019
Parkaze is an online shared-economy marketplace where you can host and rent privately owned parking spots. As a host, you get a seamless experience by leveraging your privately owned parking spot when you are away to earn more money. You still have complete control of its availability, price, and rules. As a driver, you can find cheaper and safe alternatives to parking by letting you book spots where ever you go and whenever you go.

Nitronex

Series B in 2001
Specializing in the development and manufacturing of gallium nitride-on-silicon (GaN-on-Si) RF power devices, Nitronex is the global leader in high-performance GaN-on-Si RF power devices. Nitronex develops and manufactures gallium nitride-on-silicon (GaN-on-Si) RF power devices. Nitronex was founded in 1999 by graduates of the wide bandgap program at North Carolina State University and is headquartered in Durham, North Carolina. It holds 21 patents with 17 others pending.

Parkaze, Inc.

Grant in 2019
Parkaze is an online shared-economy marketplace where you can host and rent privately owned parking spots. As a host, you get a seamless experience by leveraging your privately owned parking spot when you are away to earn more money. You still have complete control of its availability, price, and rules. As a driver, you can find cheaper and safe alternatives to parking by letting you book spots where ever you go and whenever you go.

ESGAnalytics.AI

Pre Seed Round in 2019
ESGAnalytics.AI is a FinTech startup focused on bringing cutting edge analytics approaches to the Financial Services Sector, with a focus on spatial and novel data sets around Environmental, Social, and Governance (ESG) topics. The platform has over 700 data sets, including custom metrics, predictive analytics, and AI-Driven signals.

Sandburst Corporation

Series B in 2001
Sandburst Corporation is a fabless semiconductor company, is pioneering a revolutionary new technology for the design of highly complex integrated circuits. For both Sandburst and its customers, this technology substantially reduces development costs and enables a shorter time-to-market. Sandburst is currently developing VLSI solutions specifically targeted at data communications and IP networking. These wire-speed IP packet processing components provide a solid foundation for high-performance systems without requiring the major software development effort needed for general-purpose programmable devices.
SelectX Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of aminoglycoside therapeutics for unmet medical needs. It has built an advanced aminoglycoside drug and other drugs. The company’s advanced program, development candidate SXP2523, is a next generation aminoglycoside antibiotic for drug resistant gram-negative hospital-acquired infections. SelectX Pharmaceuticals Inc. is currently developing a next generation inhaled aminoglycoside antibiotic for drug resistant gram-negative infections in patients with Cystic Fibrosis and other respiratory diseases. The company is based in Boston, Massachusetts.

Parkaze, Inc.

Grant in 2020
Parkaze is an online shared-economy marketplace where you can host and rent privately owned parking spots. As a host, you get a seamless experience by leveraging your privately owned parking spot when you are away to earn more money. You still have complete control of its availability, price, and rules. As a driver, you can find cheaper and safe alternatives to parking by letting you book spots where ever you go and whenever you go.

Parkaze, Inc.

Grant in 2020
Parkaze is an online shared-economy marketplace where you can host and rent privately owned parking spots. As a host, you get a seamless experience by leveraging your privately owned parking spot when you are away to earn more money. You still have complete control of its availability, price, and rules. As a driver, you can find cheaper and safe alternatives to parking by letting you book spots where ever you go and whenever you go.

NitroMed

Series E in 2001
NitroMed is an emerging pharmaceutical company that discovers, develops and seeks to commercialize proprietary pharmaceuticals based on the therapeutic benefits of the naturally-occurring molecule nitric oxide. NitroMed is conducting a late-stage confirmatory trial of our lead nitric oxide-enhancing drug, BiDil, for the treatment of heart failure in African Americans.

Nitronex

Series A in 2000
Specializing in the development and manufacturing of gallium nitride-on-silicon (GaN-on-Si) RF power devices, Nitronex is the global leader in high-performance GaN-on-Si RF power devices. Nitronex develops and manufactures gallium nitride-on-silicon (GaN-on-Si) RF power devices. Nitronex was founded in 1999 by graduates of the wide bandgap program at North Carolina State University and is headquartered in Durham, North Carolina. It holds 21 patents with 17 others pending.